EFFICACY AND SAFETY OF LENALIDOMIDE IN PATIENTS WITH MULTIPLE MYELOMA COMPLICATED BY EXTRAMEDULLARY PLASMACYTOMAS

被引：0
|
作者：
Calvo, J. M. [1 ]
Alegre, A. [2 ]
Garcia-Sanchez, R. [3 ]
Hernandez, M. T. [4 ]
Giraldo, P. [5 ]
Zudaire, M. [6 ]
Gusmao, B. [7 ]
Rodriguez, J. N. [8 ]
Calle, C. [9 ]
Ramirez, G. [3 ]
Inigo, B. [10 ]
Martinez, J. [11 ]
Oriol, A. [12 ]
机构：
[1] Hosp Doctor Jose Molina Orosa, Las Palmas Gran Canaria, Spain
[2] Hosp Univ La Princesa, Madrid, Spain
[3] Hosp Virgen Victoria, Malaga, Spain
[4] Hosp Univ Canarias, Tenerife, Spain
[5] Hosp Miguel Servet, Zaragoza, Spain
[6] Hosp Navarra, Navarra, Spain
[7] Hosp San Pedro, Logrono, Spain
[8] Hosp Juan Ramon Jimenez, Huelva, Spain
[9] Hosp Gen Ciudad Real, Ciudad Real, Spain
[10] Hosp Clin Univ San Carlos, Madrid, Spain
[11] Hosp 12 Octubre, E-28041 Madrid, Spain
[12] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1474
引用
收藏
页码：588 / 588
页数：1
相关论文
共 50 条
  • [41] Safety and Efficacy of Daratumumab with Lenalidomide and Dexamethasone in Relapsed or Relapsed, Refractory Multiple Myeloma
    Plesner, Torben
    Arkenau, Hendrik-Tobias
    Lokhorst, Henk M.
    Gimsing, Peter
    Krejcik, Jakub
    Lemech, Charlotte
    Minnema, Monique C.
    Lassen, Ulrik
    Laubach, Jacob P.
    Ahmadi, Tahamtan
    Yeh, Howard
    Guckert, Mary E.
    Feng, Huaibao
    Brun, Nikolai Constantin
    Lisby, Steen
    Basse, Linda
    Palumbo, Antonio
    Richardson, Paul G.
    BLOOD, 2014, 124 (21)
  • [42] Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
    M A Dimopoulos
    A S Swern
    J S Li
    M Hussein
    L Weiss
    Y Nagarwala
    R Baz
    Blood Cancer Journal, 2014, 4 : e257 - e257
  • [43] SAFETY AND EFFICACY OF DARATUMUMAB WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED OR RELAPSED, REFRACTORY MULTIPLE MYELOMA
    Plesner, T.
    Arkenau, H. T.
    Lokhorst, H. M.
    Gimsing, P.
    Krejcik, J.
    Lemech, C.
    Minnema, M. C.
    Lassen, U.
    Ahmadi, T.
    Yeh, H.
    Guckert, M.
    Brun, N. C.
    Lisby, S.
    Basse, L.
    Palumbo, A.
    Richardson, P. G.
    HAEMATOLOGICA, 2014, 99 : 104 - 104
  • [44] A comparison of the efficacy and safety of ixazomib and lenalidomide combined with dexamethasone in the treatment of multiple myeloma
    Zheng, Zhipan
    Lin, Kai
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (05): : 5248 - 5255
  • [45] Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
    Dimopoulos, M. A.
    Swern, A. S.
    Li, J. S.
    Hussein, M.
    Weiss, L.
    Nagarwala, Y.
    Baz, R.
    BLOOD CANCER JOURNAL, 2014, 4 : e257 - e257
  • [46] Efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma: a real-life experience
    Soyer, Nur
    Patir, Pusem
    Uysal, Ayse
    Duran, Mustafa
    Unal, Hatice Demet
    Durusoy, Raika
    Tombuloglu, Murat
    Sahin, Fahri
    Tobu, Mahmut
    Vural, Filiz
    Saydam, Guray
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (04) : 777 - 785
  • [47] The efficacy and safety of lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma patients with impaired renal function
    Weber, D. M.
    Spencer, A.
    Wang, M.
    Chen, C.
    Attal, M.
    Niesvizky, R.
    Prince, M.
    Yu, Z.
    Knight, R.
    Dimopoulos, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] The Efficacy and Safety of Lenalidomide Plus Dexamethasone in Relapsed and/or Refractory Multiple Myeloma Patients With Impaired Renal Function
    Dimopoulos, Meletios
    Alegre, Adrian
    Stadtmauer, Edward A.
    Goldschmidt, Hartmut
    Zonder, Jeffrey A.
    de Castro, Carlos M.
    Masliak, Zvenyslava
    Reece, Donna
    Olesnyckyj, Marta
    Yu, Zhinuan
    Weber, Donna M.
    CANCER, 2010, 116 (16) : 3807 - 3814
  • [49] Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    White, Darrell
    LeBlanc, Richard
    Venner, Chritopher
    Bahlis, Nizar J.
    Lentzsch, Suzanne
    Gasparetto, Cristina J.
    Chen, Christine
    Lipe, Brea
    Sutherland, Heather
    Tuchman, Sascha
    Baljevic, Muhamed
    Kotb, Rami
    Sebag, Michael
    Callander, Nancy
    Bensinger, William
    Kai, Kazuharu
    Liu, Jianjun
    Sheehan, Heidi
    Estepan, Daniel Nova
    Shah, Jatin
    Schiller, Gary J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E55 - E55
  • [50] Multiple solitary extramedullary anaplastic plasmacytomas
    Madi, Sandesh
    Senthil, Vishnu
    Naik, Monappa
    Vijayan, Sandeep
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2016, 37 (04) : 303 - 304
12345